Pharbers

法伯新天医药

Pharbers

Biotech/Healthcare

Founded on January 28, 2016, Faber Xintianzheng is an innovative drug development company focused on nuclear medicine, with expertise in providing end-to-end solutions for commercializing scientists' independent research. The company has pursued a three-stage strategy.

Latest round: Pre Series A (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-01-01